Announcements

Employment Opportunities

Population Genetics Faculty Position.—A tenure-track assistant professor position in population genetics will be available beginning in August, 2003, in the Department of Biological and Physical Sciences at Kennesaw State University. Preference will be given to applicants with demonstrated excellence in teaching at the college level. Applicants should have postdoctoral research experience and a strong potential for developing an externally funded research program involving undergraduates. An earned doctorate in an appropriate discipline is required. Review of applications will commence on November 1, 2002, and will continue until the position is filled. Submit a letter describing qualifications for the position, a statement of teaching philosophy, a statement of research interests, a current curriculum vitae, graduate transcripts, and the names, addresses, telephone numbers, and e-mail addresses of three references to Dr. Dale Lynn Vogelien, Population Genetics Search Committee, Department of Biological and Physical Sciences, #1202, Kennesaw State University, 1000 Chastain Road, Kennesaw, GA 30144-5591; e-mail: dvogelie@kennesaw.edu. Kennesaw State University is an affirmative action/equal opportunity employer. Women and minorities are encouraged to apply.

Medical Director.—Quest Diagnostics, Inc., is a Fortune 500 company and the worldwide leader in providing clinical diagnostic services to physicians, hospitals, and managed care organizations. We have a busy biochemical genetics laboratory using high-performance liquid chromatography, GC-MS, amino acid analyzers, LC-MS/MS, and several automated analysis platforms. The medical director is directly responsible for medical interpretations and consultations and, as the leader of the laboratory, is indirectly responsible for all aspects of laboratory operations, R&D, compliance, and quality assurance. Candidates must have an M.D. degree and will be expected to obtain a California medical license. Board certification or eligibility in biochemical genetics from the American Board of Medical Genetics is also required. Good verbal and written communication skills, as well as good decision-making capabilities, are required. Enjoy the Southern California lifestyle with interesting cases and colleagues! Quest Diagnostics, Inc., offers a competitive compensation and an excellent benefits package. For immediate consideration, please send your résumé, with salary history and requirements, to Quest Diagnostics, Inc., Attn: Charles M. Strom, M.D., Ph.D., Medical Director, Genetics, 33608 Ortega Highway, San Juan Capistrano, CA 92690-6130; e-mail: Charles.M.Strom@questdiagnostics.com. Electronic inquiries are encouraged.

Neel Distinguished Chair in Biotechnology.—The Department of Biological and Physical Sciences at Kennesaw State University is accepting applications for the Holmes Neel Distinguished Chair in Biotechnology, available August, 2003. The successful candidate will be expected to provide leadership for a recently approved baccalaureate program in biotechnology and to develop collaborations with local biotechnology industry partners. Minimum qualifications are a Ph.D. in biology or a related field, a demonstrated ability to develop a multidisciplinary research program in an area related to biotechnology, and a record of sustained extramural funding. Review of applications will commence on November 1, 2002, and will continue until the position is filled. Submit a letter describing your qualifications for the position, a statement of research interests, a plan for interacting with the local biotechnology community, a current curriculum vitae, graduate transcripts, and the names, addresses, telephone numbers, and e-mail addresses of three references to Dr. Kathleen Fleiszar, Neel Distinguished Chair Search Committee, Department of Biological and Physical Sciences, #1202, Kennesaw State University, 1000 Chastain Road, Kennesaw, GA 30144-5591; e-mail: kfleisza@kennesaw.edu. Kennesaw State University is an affirmative action/equal opportunity employer. Women and minorities are encouraged to apply.

Postdoctoral Fellowship.—This is an opportunity to join an interdisciplinary team of geneticists, urologists, pathologists, and epidemiologists to study genetic risk factors for prostate cancer development and progression at New York University Cancer Institute. The project will focus on the molecular genetic changes that occur in people from high-risk groups. Experimental approaches include the use of expression profiling and molecular cytogenetic analysis and the development of tumor biomarkers for predicting the malignant potential of lesions. Candidates must have a Ph.D., D.V.M, M.D., or equivalent degree, experience in molecular biology and genetics, American citizenship (or green card), and demonstrated productivity. The salary is competitive and will be commensurate with experience. Full benefits will be provided. The starting date will be January 1, 2003. A letter of inquiry, including a curriculum vitae and the names of three references, should be addressed to Harry Ostrer, M.D., Human Genetics Program, NYU School of Medicine, 550 First Avenue, New York, NY 10016; telephone: (212) 263-7596; fax: (212) 263-3477; e-mail ostreh01@med.nyu.edu

Meeting

International Meeting on Congenital Disorders of Glycosylation.—An international meeting on the congenital disorders of glycosylation and related disorders will be held in Giardini-Naxos, Sicily, April 2–6, 2003. The meeting will cover all aspects of these disorders, including the discovery of novel types, the study of fundamental aspects of glycosylation, analytical procedures and diagnostic methods, and the analysis of models for the disease. There will be a strong interest in the presentation of potential therapies. The meeting is organized by the members of EUROGLYCAN, a European network for the study of glycan defects, supported by the European Commission (QLG1-CT2000-00047). Further information can be obtained by contacting Prof. Gert Matthijs (the coordinator of EUROGLYCAN) by e-mail (gert.matthijs@med.kuleuven.ac.be).

Conference

The Great Lakes Chromosome Conference.—The 41st annual Great Lakes Chromosome Conference (GLCC) will be held May 15–16, 2003, in Toronto, Ontario, Canada. This conference brings together clinical cytogeneticists, cytogenetics fellows, and technologists in an informal setting to examine the themes of cancer cytogenetics, clinical problems, research programs, and new technologies. For additional information, please visit the conference Web site (http://glccontario.tripod.com/theGLCC/). If you wish to be added to the conference e-mail list, please contact meeting organizer Marsha Speevak (mspeevak@cvh.on.ca).